CIK 0000034956 · Non-accelerated filer<br>Smaller reporting company
TENAX THERAPEUTICS, INC.
Sign in to watch- Ticker
- TENX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262593535
- Phone
- 919-855-2100
- Business address
- 101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
- Former names
- OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
- Open-market buys, last 90 days
- $6,396,312
- in 7 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$6,396,312. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-16 | Doogan Declan Director | Purchase | +53,000 | $1.92 | $102K | 55,274 |
| 2026-01-09 | Doogan Declan Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2025-07-01 | Doogan Declan Director | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2024-12-10 | Doogan Declan Director | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2022-08-11 | Doogan Declan Director | Gift | −567,871 | 0 | ||
| 2022-08-11 | Doogan Declan Director | Gift | +567,871 | 3,637,871 | ||
| 2022-06-09 | Doogan Declan Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2021-06-30 | Doogan Declan Director | Gift | −567,871 | 2,502,129 | ||
| 2021-06-11 | Doogan Declan Director | Option exercise | +3,070,000 | 3,637,871 | ||
| 2021-06-11 | Doogan Declan Director | Option exercise · Series B Preferred Stock | −3,070 | 0 | ||
| 2021-06-10 | Doogan Declan Director | Grant or award · Stock Option (right to buy) | +6,250 | 6,250 |
Page 1 of 1 · 11 trades